Ramirez et al v. Monsanto Reference : 3:19- cv-02224 Complaint date : April 24, 2019 Status : Not judged Place of jurisdiction : United States, Northern District of California Plaintiffs types : Gardeners, Technicians and Professional users, Landscapers Plaintiffs names : Robert Ramirez, Jerry Agtarap, Dexter Owens, John Elko Defendants : Monsanto Lawyers for Health and Environmental Justice : William M. Audet, Ling Y. Kuang, Samuel Issacharoff Case nature : Civil court Specificities : Class action, Jury Type(s), Product(s), Active substance(s) : Herbicide, Glyphosate, Roundup Requests : Declare that Defendant is financially responsible for notifying all Class members of the link between Roundup and NHL; Declare that Defendant must disgorge, for the benefit of the Class, all or part of the illgotten profits it received from the sale of Roundup... punitive or exemplary damages; injunctive and declaratory relief... a trial by jury. Name of the Court : United States District Court of Northern District of California, United States Jurisdiction level : Summary : Plaintiff seeks to obtain a ruling on the issue of the relationship between glyphosate and the carcinogenic effects on humans. In seeking to resolve this common question in one forum, the Plaintiff expects to save millions of dollars for the class members and hundreds of thousands of hours of judicial time and resources. The case is related to: MDL No: 2471. On June 24, 2020, Bayer seeks an agreement to settle current US Roundup litigation. However, the agreement would delay any new Roundup cancer claims for years and shift the key question of whether or not the weed killer causes cancer from a jury to a hand-picked panel of scientists. On 7/6/2020, a preliminary order from Judge Chhabria states that the Court is skeptical of the propriety and fairness of the proposed settlement, and is tentatively inclined to deny the motion. On 7/8/2020, Bayer withdraws its proposal for class action settlement of future Roundup claims. On Feb. 3, 2021, Bayer announces a new $2 billion plan to resolve future Roundup cancer litigation that would compensate “qualified claimants” over a four-year program. Plaintiffs’ class counsel are filing a motion for preliminary approval of the class agreement. The plan must be approved by Judge Chhabria. It has drawn opposition from law firms and lawyers who consider that "the proposed settlement seriously undermines access to justice for millions of people in the proposed class, would prevent Monsanto's victims from holding it accountable, and would reward Monsanto in many ways." Scientific references : No scientifice reference for this case. Related links : Roundup Class Action Complaint, 04/24/2019 Bayer settles U.S. Roundup, dicamba and PCB litigation for more than $10 billion First Amended Class Action Complaint against Monsanto Motion for judge to accept class action and science panel Declaration explaining how class settlement was put together Challenge eyed to class action plan for Bayer Roundup settlement Pre-trial order 214: Denying motion to alter schedule on motion for preliminary approval Court frowns on Bayer’s proposed Roundup class-action settlement Notice of motion to withdraw class action settlement plan Bayer's agreement with plaintiffs’ counsel on class plan Bayer makes new $2 billion plan to head off future Roundup cancer claims $2 billion settlement likely excludes migrant workers exposed to Roundup Bayer’s plan for settling future Roundup cancer claims faces broad opposition National Trial Lawyers opposition to class settlement Bayer’s class action settlement plan draws widespread outrage, opposition